Find out what’s happening at Pivot Park. Stay informed on the latest collaborations, scientific breakthroughs and developments in drug discovery and life sciences. Explore how innovators at the park are shaping the future of health, technology and entrepreneurship.
Pedro Hermkens Stipend awarded to Miguel Rodríguez Fuentes
Miguel Rodríguez Fuentes of Sublin Therapeutics has been awarded the 2026 Pedro Hermkens Stipend. The stipend supports his Master’s programme in Bioinformatics and Biostatistics, helping him further develop skills that contribute to both his professional growth and innovation at Sublin Therapeutics.
Key insights from the Summer Course Essentials of Drug Discovery
From 15 to 19 June, Radboud University, in collaboration with HAN University of Applied Sciences, Crossfire Oncology and Pivot Park, organized the Summer Course Essentials of Drug Discovery, an inspiring programme that offered participants a broad and practical insight into the journey from an early scientific idea to a potential therapy.
Aspen Oss and Pivot Park ready to start construction of the fit-out of the Panther building
Pivot Park and Aspen Oss have taken another major step forward in the development of the Panther building at Pivot Park. With the construction agreement with Dura Vermeer now officially signed, works on the campus are expected to start on 15 June 2026.
Strengthening the Oss pharma cluster through the arrival of Aspen Oss at Pivot Park
Pivot Park and Aspen Oss, have signed an important lease and development agreement for Aspen Oss to occupy the Hodgkin building, commonly known as Panther, at Pivot Park.
Pivot Park donates €3,000 and food supplies to Food Bank Oss
Pivot Park has donated €3,000 and long-life food products to Food Bank Oss, highlighting its strong commitment to the local community.
Pivot Park welcomes Mark Ypinga as Chief Business Officer
We are delighted to announce Mark Ypinga as the new Chief Business Officer (CBO) of Pivot Park. In his new role, Mark will collaborate closely with our team, partners and the many inspiring companies on campus to scale the ecosystem, attract new opportunities and strengthen Pivot Park’s international profile.
Pivot Park and Aspen Oss, both located in Oss and neighbours of each other, have signed an important letter of intent for the development and lease of the Hodgkin building, commonly known as “Panther”, at Pivot Park by Aspen Oss.
Aleksandr Garin Receives €1,000 Pedro Hermkens Stipend
On Thursday, June 26, Aleksandr Garin of Organon at Pivot Park received the Pedro Hermkens Stipend from Pedro Hermkens and Brigitte Drees. Awarded during the Pivot Park Summer Event, the stipend honors the legacy of emeritus professor Pedro Hermkens of HAN University of Applied Sciences.
A celebration of community at Pivot Park’s Summer Festival
On Thursday, 26 June 2025, Pivot Park hosted its annual Summer Festival, bringing together members of our campus community for an afternoon of informal networking and engagement.
Delegation from Baden-Württemberg visits Pivot Park
On Tuesday 4 June, Pivot Park had the honour of welcoming a business delegation from Baden-Württemberg, a region in southern Germany. The visit was part of a two-day mission to the Netherlands, particularly to in Noord-Brabant, centred around the theme “Personalised Medicine: Tailor-made Solutions through Life Sciences and Diagnostics.”
Pivot Park and QuestPair: Smart labs, strong starts
Throughout 2024, the Pivot Incubator team worked hard to ensure that the laboratories were fully equipped, allowing future startups to begin immediately. We recognised that setting up a well-equipped lab can be a significant challenge for emerging businesses, which is why we prioritised providing turnkey facilities. To achieve this, we partnered with expert organisations such as QuestPair.
Supporting talent through the Pedro Hermkens stipend
At Pivot Park, we believe in empowering the people behind innovation. Through the Pedro Hermkens stipend, we support employees of campus-based companies in pursuing professional development.
The annual €1,000 stipend enables them to follow advanced courses or training to boost their skills and careers. Last year’s recipient, Josephine Stein (Citryll), completed a 10-week Harvard course in immunology.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.